Bright Peak Therapeutics AG
Next-generation engineered cytokines
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
21.10.2024
Bright Peak Therapeutics enters the clinic with first immunotherapy for cancer (startupticker.ch)
21.10.2024
Bright Peak Therapeutics enters the clinic with first immunotherapy for cancer (startupticker.ch)
17.06.2024
Bright Peak Therapeutics raises USD90 million to advance lead program into clinical trials (startupticker.ch)
14.06.2024
Bright Peak Therapeutics secures USD 90 million in Series C funding to propel innovative immunotherapy forward (venturelab.swiss)
16.12.2022
The 18 most promising biotech startups, according to investors (TOP 100)
No milestones
No Jobs
No videos and documents
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Bright Peak Therapeutics AG
Next-generation engineered cytokines
Website:
www.brightpeaktx.com
Headquarter:
Basel
Foundation Date:
December 2017
Technology:
- Biotech
Support received
